Psyched Wellness Signs Supply Agreement for Amanita Muscaria

Toronto, Ontario – May 4, 2021 – Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the “Company” or “Psyched“) a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce the Company has entered into a two year supply agreement (the “Supply Agreement“) with MB […]

Psyched Wellness Initiates the Next Pre-Clinical Trial Study on AME-1

Toronto, Ontario- April 27, 2021 –  Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the “Company” or “Psyched“) a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce that the company and its Clinical Research Organization partner, KGK Science, has commenced the next preclinical trial […]

Psyched Wellness Receives DTC Eligibility

Toronto, Ontario – April 14, 2021  – Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE:5U9) (the “Company” or “Psyched“), a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce that its common shares are now eligible for electronic clearing and settlement through the Depository Trust Company (“DTC”). […]

Psyched Wellness Initiates Study on AME-1 Extract for Gut Health

Toronto, Ontario – March 30, 2021 – Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the “Company” or “Psyched“) a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce the company has signed an additional agreement with its CRO partner, KGK Science to further study […]

Psyched Wellness Submits a Provisional Patent Application For AME-1

Toronto, Ontario – March 17, 2021 – Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the “Company” or “Psyched“) a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce the company has submitted a provisional patent application with the United States Patent and Trademark office, to […]

Psyched Wellness Announces Changes to the Board of Directors

Toronto, Ontario – March 15, 2021 – Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the “Company” or “Psyched“) a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce that Janeen Stodulski has been appointed as a director of the Corporation. Psyched also announced […]

Psyched Wellness Provides Update on Pre-Clinical Trial of Its Muscimol Extract AME-1

Toronto, Ontario – March 2, 2021 – Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the “Company” or “Psyched“), a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce the company has received the results from its Maximum Tolerated Dosage (MTD) study conducted by KGK […]

Psyched Wellness Closes $6,603,000 Bought Deal Private Placement

Toronto, Ontario-February 17, 2021 – Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the “Company“), a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce that further to its press releases dated January 21, 2021 and January 22, 2021, it has closed the bought deal private […]

Psyched Wellness Provides Update on Antioxidant and Anti-Inflammatory Study of Muscimol

Toronto, Ontario – February 4, 2021 – Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the “Company” or “Psyched“) a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to share an update on the previously announced study to determine the therapeutic values of muscimol for antioxidant and […]

Psyched Wellness to Participate in Canaccord Genuity’s New Paradigms and Treatment Approaches in Mental Health Conference

Toronto, Ontario – February 2, 2021 – Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the “Company” or “Psyched“) a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushroom derived products, is pleased to announce its CEO and COO will be presenting at Canaccord Genuity Group Inc.’s upcoming conference; New Paradigms […]